There is increasing evidence that IL24 inhibits growth of many diverse human cancers including melanomas [29], breast cancer [44], pancreatic cancer [50], gliomas [51], hepatocellular cancers [52] and ovarian cancer [53] without adversely affecting normal cells or tissues. This evidence concerns the gene IL24 and familial pancreatic carcinoma.